Showing results (1-10 of 196) with videos related to
Sort By:
Pageof 20
Current Pharmaceutical Design|May 19, 2016
Therapeutic Approaches Targeting Pathological Tau AggregatesJulia Gerson, Rakez KayedThe Journal of Biological Chemistry|July 4, 2021
Infectious etiology and amyloidosis in Alzheimer's disease: The puzzle continuesRakez KayedHuman Vaccines|October 29, 2010
Anti-tau oligomers passive vaccination for the treatment of Alzheimer diseaseRakez KayedProgress in Neurobiology|April 21, 2022
Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseasesUrmi Sengupta, Rakez KayedMethods in Molecular Biology (Clifton, N.J.)|March 21, 2024
Tau Oligomers as Pathogenic Seeds: Preparation, Characterization, and Propagation In Vitro and In VivoUrmi Sengupta, Rakez KayedCell Reports. Medicine|May 18, 2022
Quantification and targeting of elusive neurotoxic amyloid oligomersNemil Bhatt, Rakez KayedCurrent Opinion in Immunology|June 2, 2009
Prefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disordersRakez Kayed, George R JacksonMethods in Enzymology|October 19, 2006
Conformation-dependent anti-amyloid oligomer antibodiesRakez Kayed, Charles G GlabeFrontiers in Neurology|July 25, 2013
Formation and propagation of tau oligomeric seedsJulia E Gerson, Rakez KayedACS Chemical Neuroscience|January 30, 2018
Azure C Targets and Modulates Toxic Tau OligomersFilippa Lo Cascio, Rakez KayedPageof 20